1-4 of 4
Patrice Berthaud
Close
Sort by
Journal Articles

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

Andre Delannoy, MD, Véronique Lhéritier, Xavier Thomas, MD, Sylvie Castaigne, MD, Françoise Rigal-Huguet, MD, Emmanuel Raffoux, MD, Frederic Garban, MD, Ollivier Legrand, MD, Francis Witz, MD, Viviane Dubruille, MD, Pascal Turlure, MD, Xavier Troussard, MD, Martine Delain, MD, Françoise Isnard, MD, Diane Coso, MD, Pascale Raby, MD, Agnès Buzyn, MD, Sylvie Caillères, MD, Stéphane Darre, MD, Bruno Lioure, MD, Anne Sonet, MD, Chrystele Bilhou-Nabera, MD, Marie-Christine Bene, MD, Elizabeth Macintyre, MD, Eric Delabesse, MD, Jean-Paul Vernant, MD, Norbert Ifrah, MD, Hervé Dombret, MD, Patrice Berthaud, MD, Denis Fière, MD
Journal: Blood
Blood (2005) 106 (11): 146.
https://doi.org/10.1182/blood.V106.11.146.146
Published: 2005
Journal Articles

Quantification of Imatinib in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry: Applications to Therapeutic Drug Monitoring of Patients with Chronic Myelogenous Leukemia.

Francois-Xavier Mahon, MD, PhD, Stéphane Picard, MD, Karine Titier, MD, Franck Nicolini, MD, PhD, Dominique Ducint, MD, Nicolas Moore, MD, PhD, Gerald Marit, MD, Patrice Berthaud, MD, Mathieu Molimard, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1995.
https://doi.org/10.1182/blood.V106.11.1995.1995
Published: 2005
Journal Articles

A Phase I/II Dose Escalating Study of Daunorubicin Combined with Imatinib Mesylate and Cytarabine as Induction Therapy for Chronic Myelogenous Leukaemia in Myeloid Blast Crisis. Preliminary Results of the AFR01 Trial.

Philippe Rousselot, MD, Laurence Legros, MD, Joelle Guilhot, BS, Mauricette Michallet, MD, Francois Xavier Mahon, MD, Cecile Pautas, MD, Denis Guyotat, MD, Agnes Guerci, MD, Christian Berthou, MD, Bernard Rio, MD, Lydia Roy, MD, Patrice Berthaud, MD, Francois Guilhot, MD
Journal: Blood
Blood (2004) 104 (11): 1002.
https://doi.org/10.1182/blood.V104.11.1002.1002
Published: 2004
Journal Articles

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase

Clinical Trials & Observations
Martine Gardembas, Philippe Rousselot, Michel Tulliez, Magda Vigier, Agnès Buzyn, Françoise Rigal-Huguet, Laurence Legros, Mauricette Michallet, Christian Berthou, Nathalie Cheron, Frederic Maloisel, François-Xavier Mahon, Thierry Facon, Patrice Berthaud, Joëlle Guilhot, François Guilhot, for the CML French Group (FIϕLMC)
Journal: Blood
Blood (2003) 102 (13): 4298–4305.
https://doi.org/10.1182/blood-2003-04-1010
Published: 2003